Collectively, these results imply that the tumorigenic effect of myr-Akt in β-cells is mediated by rpS6 phosphorylation and is accompanied by augmented cell proliferation at the onset of the tumor progression, with p27 as a potential effector downstream of Akt and rpS6. The gene discussed is AKT1; the disease is neoplasm.